Rutgers study sheds light on how bedaquiline fights drug-resistant tuberculosis

Rutgers Health research has uncovered why a relatively new antibiotic for tuberculosis (TB) works against multidrug-resistant strains, potentially inspiring improved treatments and drug development strategies.

Hospital Leaders: Workforce Shortages Persist Amid Stabilization

What You Should Know: – Hospitals and health systems are seeing some signs of stabilization and margin improvement, but challenges around workforce, expenses and patient access

October 25, 2023

S1P Receptor Modulator May Boost Cognitive Processing Speed in Early MS

Treatment with ozanimod (Zeposia) led to clinically meaningful improvement in cognitive processing speed among people with early relapsing multiple sclerosis (RMS), an ad hoc interim

October 20, 2023

BeiGene’s TEVIMBRA receives approval for OSCC in Israel

TEVIMBRA monotherapy is indicated for treating unresectable or metastatic oesophageal squamous cell carcinoma. Credit: SewCreamStudio/Shutterstock. The Israeli Ministry of Health (IL MOH) has approved BeiGene’s

September 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.